Asensus Surgical Inc. (ASXC) News
Filter ASXC News Items
ASXC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ASXC News Highlights
- For ASXC, its 30 day story count is now at 2.
- Over the past 5 days, the trend for ASXC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest ASXC News From Around the Web
Below are the latest news stories about Asensus Surgical Inc that investors may wish to consider to help them evaluate ASXC as an investment opportunity.
Asensus Surgical Q4 2021 Earnings PreviewAsensus Surgical (NYSE:ASXC) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close. The consensus EPS Estimate is -$0.07 (+22.2% Y/Y) and the consensus Revenue Estimate is $1.5M (+35.1% Y/Y). Over the last 2 years, ASXC has beaten EPS estimates 63% of the time and has... |
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2021 Financial and Operating Results Conference Call for February 28, 2022RESEARCH TRIANGLE PARK, N.C., February 22, 2022--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 fourth quarter and fiscal year 2021 financial and operating results after the market closes on Monday, February 28, 2022. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the |
Asensus Surgical: Reimagining the Future of SurgerySetting a new standard with Performance-Guided Surgery New York, New York--(Newsfile Corp. - January 26, 2022) - -- PCG Digital-- Asensus Surgical, Inc. (NYSE American: ASXC) is leading the digital surgical market with a new concept known as Performance-Guided Surgery™. Asensus SurgicalTo view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/6513/111747_fd7e8fe144c8180c_001full.jpgWhen the smart phone in your pocket has more computing power than the standar |
Asensus Surgical trades in green on prelim FY21 corporate updateIn its prelim 2021 year-end corporate update, Asensus Surgical (ASXC) reported 500+ procedures performed globally during Q4 (+25% Y/Y) while 2K+ procedures were performed globally |
Asensus Surgical Provides Preliminary 2021 Year-End Corporate UpdateRESEARCH TRIANGLE PARK, N.C., January 10, 2022--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. |
Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect 2022 ConferenceRESEARCH TRIANGLE PARK, N.C., December 29, 2021--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company’s virtual presentation will take place on Thursday, January 13, 2022 at 9:00 am Eastern Time. |
Asensus Surgical Inc. (ASXC) Is A Buy Stock For Small Caps AnalystsAsensus Surgical Inc. (AMEX:ASXC) has a beta value of 1.51 and has seen 3.82 million shares traded in the last trading session. The company, currently valued at $241.01M, closed the last trade at $1.13 per share which meant it lost -$0.09 on the day or -7.38% during that session. The ASXC stock price is -515.04% Asensus Surgical Inc. (ASXC) Is A Buy Stock For Small Caps Analysts Read More » |
Analyzing Asensus Surgical (NYSE:ASXC) & Procept BioRobotics (NASDAQ:PRCT)Asensus Surgical (NYSE:ASXC) and Procept BioRobotics (NASDAQ:PRCT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Analyst Ratings This is a breakdown of current recommendations and price targets for Asensus Surgical [] |
AI-based Surgical Robots: Market Integration of Latest Technologies into Existent Offerings with Key Players | TransEnterix, Mazor Robotics, Stereotaxis, Medrobotics CorpQurates most recent research report on AI-based Surgical Robots was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on AI-based Surgical Robots is extensive and consist of |
Co-Diagnostics (NASDAQ:CODX) vs. Asensus Surgical (NYSE:ASXC) Financial ReviewCo-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Insider and Institutional Ownership 25.6% of Co-Diagnostics shares are held by institutional investors. Comparatively, 24.8% of [] |